demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comers
COVID 19 all comers
antiviral and associated therapy
chloroquine and derivatives
hydroxychloroquine NOR-Solidarity ...
favipiravir Lou ... Chang Chen et al. NCT04310228-FAVI ...
remdesivir Andreas ... Norwegian NOR study ...
umifenovir (arbidol) ELACOI ...

13 studies excluded by filtering options 0

4823 Jun C, 2020 113high risk of bias
4861 Cai -FAVIPIRAVIR, 2020 1310not a RCTrisk of bias not avaialble
4899 ChiCTR2000029826 (Cancelled by the investigator), 0 210excludedrisk of bias not avaialble
4905 ChiCTR2000029975, 0 2300excludednot a RCTrisk of bias not avaialble
4980 jRCTs041190120, 2020 113high risk of bias
4987 CloroCOVID19, 2020 213excludedhigh risk of bias
5288 Barbosa, 2020 2130excludednot a RCTrisk of bias not avaialble
5314 Magagnoli (HC AZ), 2020 1133not a RCThigh risk of bias
5351 Mallat, 2020 2130excludednot a RCTrisk of bias not avaialble
6246 IRCT20150808023559N20, 0 010selection pending
6252 NCT04376814-Group A, 2020 0310selection pending
6263 Calik, 2020 1104not a RCThigh risk of bias
9263 EPIC-SR, 0 110risk of bias not avaialble